Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells
- PMID: 16502257
- DOI: 10.1007/s10495-006-3715-4
Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells
Abstract
Peptidylarginine deiminases (PADIs) convert peptidylarginine into citrulline via posttranslational modification. One member of the family, PADI4, plays an important role in immune cell differentiation and cell death. To elucidate the participation of PADI4 in haematopoietic cell death, we examine whether inducible overexpression of PADI4 enhances the apoptotic cell death. PADI4 reduced the viability in a dose- and time-dependent manner of human leukemia HL-60 cells and human acute T leukemia Jurkat cells. The apoptosis-inducing activities were determined by nuclear condensation, DNA fragmentation, sub-G1 appearance, loss of mitochondrial membrane potential (delta psi(m)), release of mitochondrial cytochrome c into cytoplasm and proteolytic activation of caspase 9 and 3. Following PADI4 overexpression, cells arrest in G1 phase significantly before their entrance into apoptotic cell death. PADI4 increases tumor suppressor p53 and its downstream p21 to control cell cycle. In the detections of protein expression and kinase activity, all protein levels of cyclin-dependent kinases (CDKs) and cyclins are not reduced except cyclin D, however, CDK2 (G1 entry S phase) and CDK1 (G2 entry M phase) enzyme activities are inhibited by conditionally inducible PADI4. p53 also expands its other downstream Bax to induce cytochrome c release from mitochondria. According to these data, we suggest that PADI4 induces apoptosis mainly through cell cycle arrest and mitochondria-mediated pathway. Furthermore, p53 features in PADI4-induced apoptosis by increasing intracellular p21 to control cell cycle and by Bax accumulation to decline Bcl-2 function, destroy delta psi(m), release cytochrome c to cytoplasm and activate the caspase cascade.
Similar articles
-
Antizyme, a natural ornithine decarboxylase inhibitor, induces apoptosis of haematopoietic cells through mitochondrial membrane depolarization and caspases' cascade.Apoptosis. 2006 Oct;11(10):1773-88. doi: 10.1007/s10495-006-9512-2. Apoptosis. 2006. PMID: 16927018
-
The functional haplotype of peptidylarginine deiminase IV (S55G, A82V and A112G) associated with susceptibility to rheumatoid arthritis dominates apoptosis of acute T leukemia Jurkat cells.Apoptosis. 2007 Mar;12(3):475-87. doi: 10.1007/s10495-006-0005-0. Epub 2007 Jan 11. Apoptosis. 2007. PMID: 17216583
-
Ornithine decarboxylase prevents tumor necrosis factor alpha-induced apoptosis by decreasing intracellular reactive oxygen species.Apoptosis. 2005 May;10(3):569-81. doi: 10.1007/s10495-005-1891-2. Apoptosis. 2005. PMID: 15909119
-
Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas.In Vivo. 2005 Mar-Apr;19(2):439-53. In Vivo. 2005. PMID: 15796209 Review.
-
Peptidylarginine deiminase 4 and citrullination in health and disease.Autoimmun Rev. 2010 Jan;9(3):158-60. doi: 10.1016/j.autrev.2009.06.002. Epub 2009 Jun 18. Autoimmun Rev. 2010. PMID: 19540364 Review.
Cited by
-
PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures.Front Immunol. 2012 Oct 4;3:307. doi: 10.3389/fimmu.2012.00307. eCollection 2012. Front Immunol. 2012. PMID: 23060885 Free PMC article.
-
Long-range enhancer associated with chromatin looping allows AP-1 regulation of the peptidylarginine deiminase 3 gene in differentiated keratinocyte.PLoS One. 2008;3(10):e3408. doi: 10.1371/journal.pone.0003408. Epub 2008 Oct 16. PLoS One. 2008. PMID: 18923650 Free PMC article.
-
The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.Tumour Biol. 2016 Apr;37(4):5375-83. doi: 10.1007/s13277-015-4363-5. Epub 2015 Nov 12. Tumour Biol. 2016. PMID: 26563365
-
Epitope Specificity of Anti-Citrullinated Protein Antibodies.Antibodies (Basel). 2017 Mar 8;6(1):5. doi: 10.3390/antib6010005. Antibodies (Basel). 2017. PMID: 31548521 Free PMC article. Review.
-
The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.J Med Chem. 2011 Oct 13;54(19):6919-35. doi: 10.1021/jm2008985. Epub 2011 Sep 16. J Med Chem. 2011. PMID: 21882827 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous